Cancer & Metabolism

Scope & Guideline

Unraveling the Links Between Cancer and Metabolism

Introduction

Immerse yourself in the scholarly insights of Cancer & Metabolism with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationCANCER METAB / Cancer Metab.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Cancer & Metabolism' is dedicated to advancing the understanding of the complex interplay between cancer and metabolic processes. It emphasizes innovative research that dissects metabolic pathways within various cancer types, aiming to uncover therapeutic targets and biomarkers for improved cancer treatment and patient outcomes.
  1. Metabolic Pathways in Cancer:
    The journal focuses on elucidating the various metabolic pathways utilized by cancer cells, including glycolysis, oxidative phosphorylation, and lipid metabolism, to understand how these processes contribute to tumor growth and survival.
  2. Tumor Microenvironment Interactions:
    Research published in the journal often explores how the tumor microenvironment, including stromal and immune cell interactions, affects cancer metabolism and influences treatment responses.
  3. Therapeutic Targeting of Metabolism:
    A significant aim of the journal is to highlight studies that investigate metabolic vulnerabilities in cancer cells, identifying potential therapeutic targets that can be exploited for cancer treatment.
  4. Metabolomics and Biomarkers:
    The journal emphasizes the role of metabolomics in identifying biomarkers for cancer diagnosis, prognosis, and treatment response, contributing to personalized medicine approaches.
  5. Preclinical and Clinical Studies:
    'Cancer & Metabolism' publishes both preclinical and clinical research, bridging the gap between laboratory findings and their application in patient care.
The journal 'Cancer & Metabolism' has seen an increase in research themes that reflect current scientific interests and advancements in the field. These emerging scopes highlight the evolving understanding of cancer metabolism and its implications for therapy.
  1. Metabolic Reprogramming and Plasticity:
    Recent publications emphasize the ability of cancer cells to adapt their metabolism in response to microenvironmental changes, which is crucial for understanding treatment resistance and tumor progression.
  2. Role of Inflammation in Cancer Metabolism:
    There is a growing interest in how systemic inflammation and the immune response affect cancer metabolism, highlighting the importance of these interactions in tumor biology and treatment outcomes.
  3. Targeting Metabolic Checkpoints:
    Research focusing on metabolic checkpoint inhibitors and their potential to enhance anti-tumor immunity is gaining traction, reflecting an innovative approach to cancer therapy.
  4. Dietary Interventions and Cancer Metabolism:
    Emerging studies are examining the impact of dietary patterns on cancer metabolism, suggesting that nutritional strategies may play a role in cancer prevention and management.
  5. Integrative Omics Approaches:
    The use of integrative omics (metabolomics, proteomics, genomics) to provide a comprehensive understanding of cancer metabolism and its complexities is increasingly prominent in recent publications.

Declining or Waning

While 'Cancer & Metabolism' has consistently contributed to the understanding of cancer-related metabolic processes, certain themes have shown a decline in prominence over recent years. This reflects shifts in research focus and the evolving landscape of cancer metabolism studies.
  1. Basic Biochemical Pathways:
    There appears to be a waning focus on fundamental biochemical pathways in cancer metabolism, as the field shifts towards more complex interactions within the tumor microenvironment and systemic metabolic changes.
  2. Single Cancer Type Studies:
    Research focusing exclusively on a single type of cancer without considering broader metabolic implications or cross-cancer comparisons has declined, as there is a growing trend towards integrative approaches that encompass multiple cancer types.
  3. Static Metabolic Profiling:
    Studies that provide static metabolic profiles without dynamic assessments or functional analyses are becoming less common, as the field increasingly values real-time and functional metabolic assessments.
  4. Traditional Cancer Treatment Modalities:
    There is a noticeable decrease in research centered on traditional chemotherapy and radiation alone, with a shift towards exploring combination therapies that target metabolic pathways alongside conventional treatments.

Similar Journals

CELLULAR ONCOLOGY

Advancing Cancer Research at the Cellular Level
Publisher: SPRINGERISSN: 2211-3428Frequency: 6 issues/year

CELLULAR ONCOLOGY is an esteemed open access journal published by SPRINGER since 2004, specializing in the dynamic field of oncological research. With its ISSN 2211-3428 and E-ISSN 2211-3436, this journal plays a pivotal role in disseminating cutting-edge findings and innovative methodologies that address cancer at the cellular level. The journal has consistently achieved high-impact recognition, currently holding a Q2 rating in Cancer Research and Q1 rankings in Medicine (miscellaneous), Molecular Medicine, and Oncology as of 2023. Furthermore, it ranks 56th in oncology medicine and 48th in cancer research according to Scopus, placing it firmly within the top echelons of its field. Published in the Netherlands, with an aim to connect scientists, clinicians, and practitioners worldwide, CELLULAR ONCOLOGY fosters a collaborative environment for researchers to share insights, enhance understanding, and advance treatments. The journal’s open access model ensures that ground-breaking research is freely available, facilitating greater visibility and impact within the scientific community and beyond.

Annual Review of Cancer Biology

Charting New Directions in Cancer Studies
Publisher: ANNUAL REVIEWSISSN: 2472-3428Frequency: 1 issue/year

Annual Review of Cancer Biology is a pivotal journal published by Annual Reviews, specializing in the rapidly evolving field of cancer research. With an impact factor positioned in the distinguished Q1 quartile of Cancer Research, Cell Biology, and Oncology categories, this journal ensures that it showcases the highest quality of scholarly contributions. Indexed in Scopus, it ranks among the top in its fields, reflecting its strong influence and relevance, with remarkable percentiles indicating its esteemed position within the research community. Although not an open-access journal, it provides a comprehensive platform for advancing the frontiers of cancer biology through rigorously curated reviews, highlighting key developments, breakthroughs, and future directions that inform both academia and clinical applications. As a valuable resource for researchers, professionals, and students, the Annual Review of Cancer Biology serves as an essential guide for understanding and addressing the complexities of cancer biology today.

CANCER BIOLOGY & THERAPY

Empowering breakthroughs in cancer biology and therapy.
Publisher: TAYLOR & FRANCIS INCISSN: 1538-4047Frequency: 12 issues/year

CANCER BIOLOGY & THERAPY is a premier open-access journal published by Taylor & Francis Inc, dedicated to advancing the field of cancer research and treatment. Since its inception in 2002, the journal has evolved to provide a platform for innovative research and groundbreaking findings, addressing critical aspects of cancer biology, pharmacology, and molecular medicine. With an impressive impact factor and recognition as a Q2 journal in vital categories such as Cancer Research, Oncology, and Pharmacology, it holds significant standing in Scopus rankings, reflecting its influence and commitment to disseminating high-quality research. Offering researchers, professionals, and students a wealth of knowledge, CANCER BIOLOGY & THERAPY stands at the forefront of the fight against cancer, presenting the latest developments and therapeutic strategies vital for improving patient outcomes. Accessible to all since 2022, this journal is a must-read for anyone involved in the multifaceted arena of cancer research and treatment.

Cancer Communications

Pioneering Discoveries in Cancer Communications
Publisher: WILEYISSN: Frequency: 12 issues/year

Cancer Communications, published by WILEY, is a leading open-access journal that has positioned itself at the forefront of cancer research and oncology since its inception in 2017. With an impressive HIndex reflective of its scholarly impact and recognized in the Q1 category for both Cancer Research and Oncology as of 2023, this journal consistently ranks in the top echelons of its field, specifically at Rank #16/404 and Rank #13/230 in their respective categories on Scopus. Cancer Communications aims to disseminate cutting-edge research findings, innovative methodologies, and significant advancements in cancer treatments, thereby fostering a deeper understanding of oncology among researchers, healthcare professionals, and students. The journal operates under an Open Access model since 2018, ensuring that vital research is accessible to a global audience, thus enhancing collaboration and knowledge sharing necessary to tackle one of the most pressing health challenges of our time. Located in Hoboken, NJ, United States, and with a strong commitment to scientific excellence, Cancer Communications remains an essential resource for anyone engaged in the fight against cancer.

Genes & Diseases

Shedding light on the genetic foundations of disease.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

BMB Reports

Elevating Research, Enhancing Visibility
Publisher: KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGYISSN: 1976-6696Frequency: 12 issues/year

BMB Reports is a distinguished open-access journal published by the Korean Society of Biochemistry & Molecular Biology since 2008, making significant contributions to the fields of biochemistry, molecular biology, and medicine. With a current impact factor that positions it in the Q2 category for Biochemistry and Q1 for Miscellaneous Medicine, this journal supports a wide dissemination of high-quality research findings, fostering robust dialogue among researchers, professionals, and students alike. Based in Seoul, South Korea, BMB Reports aims to publish innovative studies that advance our understanding of biochemical and molecular processes, thus shaping the future of health and medicine. The journal's commitment to open access enhances the visibility of its articles, allowing for greater accessibility and engagement in the scientific community. With notable rankings in both the Biochemistry and Molecular Biology categories, BMB Reports stands as a vital resource for those seeking to stay at the forefront of research in these rapidly evolving disciplines.

BIOCHEMICAL JOURNAL

Exploring the Depths of Cellular Mechanisms
Publisher: PORTLAND PRESS LTDISSN: 0264-6021Frequency: 24 issues/year

BIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.

Cell Communication and Signaling

Exploring the Nuances of Molecular Signaling
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

Cancer Immunology Research

Elevating Knowledge in Cancer and Immunology
Publisher: AMER ASSOC CANCER RESEARCHISSN: 2326-6066Frequency: 12 issues/year

Cancer Immunology Research is a leading journal dedicated to the rapidly evolving field of cancer immunology, published by the American Association for Cancer Research. Established in 2013, this prestigious journal has quickly made a significant impact in its domain, achieving a 2023 Q1 ranking in both Cancer Research and Immunology. With an impressive Scopus rank of 24 out of 230 in cancer research and 28 out of 236 in immunology, it occupies a valuable position for researchers, professionals, and students engaged in cutting-edge cancer studies. Although it does not offer open access, the journal is committed to disseminating high-quality, peer-reviewed research that advances our understanding of the immune system’s role in cancer. The journal's objectives include fostering innovative studies, enhancing collaboration across disciplines, and promoting the translation of research findings into clinical applications, making it a vital resource for anyone invested in cancer therapy and immunological research.

NEOPLASMA

Deepening Understanding of Neoplastic Mechanisms
Publisher: AEPRESS SROISSN: 0028-2685Frequency: 6 issues/year

NEOPLASMA is a prominent journal published by AEPRESS SRO, dedicated to the multifaceted field of oncology and cancer research. Since its inception in 1957, this esteemed publication has served as a vital platform for advancing the understanding of neoplastic diseases, disseminating high-quality research findings that contribute to clinical and laboratory advancements. Operating under a robust framework of peer review, NEOPLASMA holds significant credibility, as evidenced by its Q2 ranking in the Medicine (miscellaneous) category and Q3 rankings in both Cancer Research and Oncology for 2023. Furthermore, with an ISSN of 0028-2685 and E-ISSN 1338-4317, the journal fosters accessibility to valuable scientific content despite the absence of open access options. Positioned in Bratislava, Slovakia, NEOPLASMA continues to attract a global readership, making substantial contributions to the fields of biochemistry, genetics, and molecular biology as highlighted by its Scopus rankings. This journal is essential reading for researchers, professionals, and students looking to stay abreast of the latest developments in cancer research and treatment strategies.